Pharmaceuticals

EMEA Europe Middle East and Africa Human Milk Oligosaccharides HMO Market Report 2017

  • QYR1450533
  • 104 Pages
  • August 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the EMEA Human Milk Oligosaccharides (HMO) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (g), revenue (Million USD), market share and growth rate of Human Milk Oligosaccharides (HMO) for these regions, from 2012 to 2022 (forecast)

Europe: Germany, France, UK, Russia, Italy and Benelux;

Middle East: Saudi Arabia, Israel, UAE and Iran;

Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Milk Oligosaccharides (HMO) market competition by top manufacturers/players, with Human Milk Oligosaccharides (HMO) sales volume (g), price (USD/mg), revenue (Million USD) and market share for each manufacturer/player; the top players including

Inbiose

Elicityl SA

Jennewein Biotechnologie

Glycom

ZuChem

Dextra Laboratories

...

On the basis of product, this report displays the sales volume (g), revenue (Million USD), product price (USD/mg), market share and growth rate of each type, primarily split into

Neutral

Acidic

Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (g), market share and growth rate of Human Milk Oligosaccharides (HMO) for each application, including

Infant formula

Functional food & beverages

Food supplements

Others

Table of Contents

EMEA (Europe, Middle East and Africa) Human Milk Oligosaccharides (HMO) Market Report 2017

1 Human Milk Oligosaccharides (HMO) Overview

1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)

1.2 Classification of Human Milk Oligosaccharides (HMO)

1.2.1 EMEA Human Milk Oligosaccharides (HMO) Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 EMEA Human Milk Oligosaccharides (HMO) Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Neutral

1.2.4 Acidic

1.2.5 Other

1.3 EMEA Human Milk Oligosaccharides (HMO) Market by Application/End Users

1.3.1 EMEA Human Milk Oligosaccharides (HMO) Sales (Volume) and Market Share Comparison by Application (2012-2022

1.3.2 Infant formula

1.3.3 Functional food & beverages

1.3.4 Food supplements

1.3.5 Others

1.4 EMEA Human Milk Oligosaccharides (HMO) Market by Region

1.4.1 EMEA Human Milk Oligosaccharides (HMO) Market Size (Value) Comparison by Region (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 Middle East Status and Prospect (2012-2022)

1.4.4 Africa Status and Prospect (2012-2022)

1.5 EMEA Market Size (Value and Volume) of Human Milk Oligosaccharides (HMO) (2012-2022)

1.5.1 EMEA Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2022)

1.5.2 EMEA Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2022)

2 EMEA Human Milk Oligosaccharides (HMO) Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Human Milk Oligosaccharides (HMO) Market Competition by Players/Manufacturers

2.1.1 EMEA Human Milk Oligosaccharides (HMO) Sales Volume and Market Share of Major Players (2012-2017)

2.1.2 EMEA Human Milk Oligosaccharides (HMO) Revenue and Share by Players (2012-2017)

2.1.3 EMEA Human Milk Oligosaccharides (HMO) Sale Price by Players (2012-2017)

2.2 EMEA Human Milk Oligosaccharides (HMO) (Volume and Value) by Type/Product Category

2.2.1 EMEA Human Milk Oligosaccharides (HMO) Sales and Market Share by Type (2012-2017)

2.2.2 EMEA Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2012-2017)

2.2.3 EMEA Human Milk Oligosaccharides (HMO) Sale Price by Type (2012-2017)

2.3 EMEA Human Milk Oligosaccharides (HMO) (Volume) by Application

2.4 EMEA Human Milk Oligosaccharides (HMO) (Volume and Value) by Region

2.4.1 EMEA Human Milk Oligosaccharides (HMO) Sales and Market Share by Region (2012-2017)

2.4.2 EMEA Human Milk Oligosaccharides (HMO) Revenue and Market Share by Region (2012-2017)

2.4.3 EMEA Human Milk Oligosaccharides (HMO) Sales Price by Region (2012-2017)

3 Europe Human Milk Oligosaccharides (HMO) (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Human Milk Oligosaccharides (HMO) Sales and Value (2012-2017)

3.1.1 Europe Human Milk Oligosaccharides (HMO) Sales Volume and Growth Rate (2012-2017)

3.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2017)

3.2 Europe Human Milk Oligosaccharides (HMO) Sales and Market Share by Type

3.3 Europe Human Milk Oligosaccharides (HMO) Sales and Market Share by Application

3.4 Europe Human Milk Oligosaccharides (HMO) Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Human Milk Oligosaccharides (HMO) Sales Volume by Countries (2012-2017)

3.4.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)

3.4.3 Germany Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

3.4.4 France Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

3.4.5 UK Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

3.4.6 Russia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

3.4.7 Italy Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

3.4.8 Benelux Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

4 Middle East Human Milk Oligosaccharides (HMO) (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Human Milk Oligosaccharides (HMO) Sales and Value (2012-2017)

4.1.1 Middle East Human Milk Oligosaccharides (HMO) Sales Volume and Growth Rate (2012-2017)

4.1.2 Middle East Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2017)

4.2 Middle East Human Milk Oligosaccharides (HMO) Sales and Market Share by Type

4.3 Middle East Human Milk Oligosaccharides (HMO) Sales and Market Share by Application

4.4 Middle East Human Milk Oligosaccharides (HMO) Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Human Milk Oligosaccharides (HMO) Sales Volume by Countries (2012-2017)

4.4.2 Middle East Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)

4.4.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

4.4.4 Israel Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

4.4.5 UAE Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

4.4.6 Iran Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

5 Africa Human Milk Oligosaccharides (HMO) (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Human Milk Oligosaccharides (HMO) Sales and Value (2012-2017)

5.1.1 Africa Human Milk Oligosaccharides (HMO) Sales Volume and Growth Rate (2012-2017)

5.1.2 Africa Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2017)

5.2 Africa Human Milk Oligosaccharides (HMO) Sales and Market Share by Type

5.3 Africa Human Milk Oligosaccharides (HMO) Sales and Market Share by Application

5.4 Africa Human Milk Oligosaccharides (HMO) Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Human Milk Oligosaccharides (HMO) Sales Volume by Countries (2012-2017)

5.4.2 Africa Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)

5.4.3 South Africa Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

5.4.4 Nigeria Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

5.4.5 Egypt Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

5.4.6 Algeria Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2017)

6 EMEA Human Milk Oligosaccharides (HMO) Manufacturers/Players Profiles and Sales Data

6.1 Inbiose

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Human Milk Oligosaccharides (HMO) Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Elicityl SA

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Human Milk Oligosaccharides (HMO) Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Jennewein Biotechnologie

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Human Milk Oligosaccharides (HMO) Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Glycom

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Human Milk Oligosaccharides (HMO) Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 ZuChem

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Human Milk Oligosaccharides (HMO) Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Dextra Laboratories

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Human Milk Oligosaccharides (HMO) Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

...

7 Human Milk Oligosaccharides (HMO) Manufacturing Cost Analysis

7.1 Human Milk Oligosaccharides (HMO) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Human Milk Oligosaccharides (HMO) Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Human Milk Oligosaccharides (HMO) Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Human Milk Oligosaccharides (HMO) Market Forecast (2017-2022)

11.1 EMEA Human Milk Oligosaccharides (HMO) Sales, Revenue and Price Forecast (2017-2022)

11.1.1 EMEA Human Milk Oligosaccharides (HMO) Sales and Growth Rate Forecast (2017-2022)

11.1.2 EMEA Human Milk Oligosaccharides (HMO) Revenue and Growth Rate Forecast (2017-2022)

11.1.3 EMEA Human Milk Oligosaccharides (HMO) Price and Trend Forecast (2017-2022)

11.2 EMEA Human Milk Oligosaccharides (HMO) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.3 Europe Human Milk Oligosaccharides (HMO) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.4 Middle Eastt Human Milk Oligosaccharides (HMO) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.5 Africa Human Milk Oligosaccharides (HMO) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.6 EMEA Human Milk Oligosaccharides (HMO) Sales Forecast by Type (2017-2022)

11.7 EMEA Human Milk Oligosaccharides (HMO) Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Human Milk Oligosaccharides (HMO)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Volume (g) by Type (2012-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Type (Product Category) in 2016

Figure Neutral Product Picture

Figure Acidic Product Picture

Figure Other Product Picture

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Volume (g) by Application (2012-2022)

Figure EMEA Sales Market Share of Human Milk Oligosaccharides (HMO) by Application in 2016

Figure Infant formula Examples

Figure Functional food & beverages Examples

Figure Food supplements Examples

Figure Others Examples

Figure EMEA Human Milk Oligosaccharides (HMO) Market Size (Million USD) by Region (2012-2022)

Figure Europe Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Human Milk Oligosaccharides (HMO) Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Middle East Human Milk Oligosaccharides (HMO) Revenue (Million USD) Status and Forecast by Countries

Figure Africa Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Africa Human Milk Oligosaccharides (HMO) Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Volume and Growth Rate (2012-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Market Major Players Product Sales Volume (g) (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales Volume (g) of Major Players (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales Share by Players (2012-2017)

Figure 2016 Human Milk Oligosaccharides (HMO) Sales Share by Players

Figure 2017 Human Milk Oligosaccharides (HMO) Sales Share by Players

Figure EMEA Human Milk Oligosaccharides (HMO) Market Major Players Product Revenue (Million USD) (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Revenue (Million USD) by Players (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Revenue Share by Players (2012-2017)

Table 2016 EMEA Human Milk Oligosaccharides (HMO) Revenue Share by Players

Table 2017 EMEA Human Milk Oligosaccharides (HMO) Revenue Share by Players

Table EMEA Human Milk Oligosaccharides (HMO) Sale Price (USD/mg) by Players (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales (g) and Market Share by Type (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales Share by Type (2012-2017)

Figure Sales Market Share of Human Milk Oligosaccharides (HMO) by Type (2012-2017)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Market Share by Type (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Human Milk Oligosaccharides (HMO) by Type in 2016

Table EMEA Human Milk Oligosaccharides (HMO) Sale Price (USD/mg) by Type (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales (g) and Market Share by Application (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales Share by Application (2012-2017)

Figure Sales Market Share of Human Milk Oligosaccharides (HMO) by Application (2012-2017)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Market Share by Application in 2016

Table EMEA Human Milk Oligosaccharides (HMO) Sales (g) and Market Share by Region (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Sales Share by Region (2012-2017)

Figure Sales Market Share of Human Milk Oligosaccharides (HMO) by Region (2012-2017)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Market Share in 2016

Table EMEA Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Market Share by Region (2012-2017)

Table EMEA Human Milk Oligosaccharides (HMO) Revenue Share by Region (2012-2017)

Figure Revenue Market Share of Human Milk Oligosaccharides (HMO) by Region (2012-2017)

Figure EMEA Human Milk Oligosaccharides (HMO) Revenue Market Share Regions in 2016

Table EMEA Human Milk Oligosaccharides (HMO) Sales Price (USD/mg) by Region (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2017)

Table Europe Human Milk Oligosaccharides (HMO) Sales (g) by Type (2012-2017)

Table Europe Human Milk Oligosaccharides (HMO) Market Share by Type (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Market Share by Type in 2016

Table Europe Human Milk Oligosaccharides (HMO) Sales (g) by Application (2012-2017)

Table Europe Human Milk Oligosaccharides (HMO) Market Share by Application (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Market Share by Application in 2016

Table Europe Human Milk Oligosaccharides (HMO) Sales (g) by Countries (2012-2017)

Table Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Countries (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Countries (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Countries in 2016

Table Europe Human Milk Oligosaccharides (HMO) Revenue (Million USD) by Countries (2012-2017)

Table Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries (2012-2017)

Figure Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries in 2016

Figure Germany Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure France Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure UK Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Russia Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Italy Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Benelux Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2017)

Table Middle East Human Milk Oligosaccharides (HMO) Sales (g) by Type (2012-2017)

Table Middle East Human Milk Oligosaccharides (HMO) Market Share by Type (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Market Share by Type (2012-2017)

Table Middle East Human Milk Oligosaccharides (HMO) Sales (g) by Applications (2012-2017)

Table Middle East Human Milk Oligosaccharides (HMO) Market Share by Applications (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Sales Market Share by Application in 2016

Table Middle East Human Milk Oligosaccharides (HMO) Sales Volume (g) by Countries (2012-2017)

Table Middle East Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Countries (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Countries in 2016

Table Middle East Human Milk Oligosaccharides (HMO) Revenue (Million USD) by Countries (2012-2017)

Table Middle East Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries (2012-2017)

Figure Middle East Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries in 2016

Figure Saudi Arabia Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Israel Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure UAE Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Iran Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2017)

Table Africa Human Milk Oligosaccharides (HMO) Sales (g) by Type (2012-2017)

Table Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Type in 2016

Table Africa Human Milk Oligosaccharides (HMO) Sales (g) by Application (2012-2017)

Table Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)

Table Africa Human Milk Oligosaccharides (HMO) Sales Volume (g) by Countries (2012-2017)

Table Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Countries (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Countries (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Countries in 2016

Table Africa Human Milk Oligosaccharides (HMO) Revenue (Million USD) by Countries (2012-2017)

Table Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries (2012-2017)

Figure Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Countries in 2016

Figure South Africa Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Nigeria Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Egypt Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Algeria Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Table Inbiose Human Milk Oligosaccharides (HMO) Basic Information List

Table Inbiose Human Milk Oligosaccharides (HMO) Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2012-2017)

Figure Inbiose Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Inbiose Human Milk Oligosaccharides (HMO) Sales Market Share in EMEA (2012-2017)

Figure Inbiose Human Milk Oligosaccharides (HMO) Revenue Market Share in EMEA (2012-2017)

Table Elicityl SA Human Milk Oligosaccharides (HMO) Basic Information List

Table Elicityl SA Human Milk Oligosaccharides (HMO) Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2012-2017)

Figure Elicityl SA Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Elicityl SA Human Milk Oligosaccharides (HMO) Sales Market Share in EMEA (2012-2017)

Figure Elicityl SA Human Milk Oligosaccharides (HMO) Revenue Market Share in EMEA (2012-2017)

Table Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Basic Information List

Table Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2012-2017)

Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales Market Share in EMEA (2012-2017)

Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue Market Share in EMEA (2012-2017)

Table Glycom Human Milk Oligosaccharides (HMO) Basic Information List

Table Glycom Human Milk Oligosaccharides (HMO) Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2012-2017)

Figure Glycom Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Glycom Human Milk Oligosaccharides (HMO) Sales Market Share in EMEA (2012-2017)

Figure Glycom Human Milk Oligosaccharides (HMO) Revenue Market Share in EMEA (2012-2017)

Table ZuChem Human Milk Oligosaccharides (HMO) Basic Information List

Table ZuChem Human Milk Oligosaccharides (HMO) Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2012-2017)

Figure ZuChem Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure ZuChem Human Milk Oligosaccharides (HMO) Sales Market Share in EMEA (2012-2017)

Figure ZuChem Human Milk Oligosaccharides (HMO) Revenue Market Share in EMEA (2012-2017)

Table Dextra Laboratories Human Milk Oligosaccharides (HMO) Basic Information List

Table Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2012-2017)

Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate (2012-2017)

Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales Market Share in EMEA (2012-2017)

Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue Market Share in EMEA (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Human Milk Oligosaccharides (HMO)

Figure Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)

Figure Human Milk Oligosaccharides (HMO) Industrial Chain Analysis

Table Raw Materials Sources of Human Milk Oligosaccharides (HMO) Major Manufacturers in 2016

Table Major Buyers of Human Milk Oligosaccharides (HMO)

Table Distributors/Traders List

Figure EMEA Human Milk Oligosaccharides (HMO) Sales (g) and Growth Rate Forecast (2017-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Revenue and Growth Rate Forecast (2017-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Price (USD/mg) and Trend Forecast (2017-2022)

Table EMEA Human Milk Oligosaccharides (HMO) Sales (g) Forecast by Region (2017-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Region (2017-2022)

Table EMEA Human Milk Oligosaccharides (HMO) Revenue (Million USD) Forecast by Region (2017-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Region (2017-2022)

Table Europe Human Milk Oligosaccharides (HMO) Sales (g) Forecast by Countries (2017-2022)

Figure Europe Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Countries (2017-2022)

Table Europe Human Milk Oligosaccharides (HMO) Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Europe Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Countries (2017-2022)

Table Middle East Human Milk Oligosaccharides (HMO) Sales (g) Forecast by Countries (2017-2022)

Figure Middle East Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Countries (2017-2022)

Table Middle East Human Milk Oligosaccharides (HMO) Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Middle East Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Countries (2017-2022)

Table Africa Human Milk Oligosaccharides (HMO) Sales (g) Forecast by Countries (2017-2022)

Figure Africa Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Countries (2017-2022)

Table Africa Human Milk Oligosaccharides (HMO) Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Africa Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Countries (2017-2022)

Table EMEA Human Milk Oligosaccharides (HMO) Sales (g) Forecast by Type (2017-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Type (2017-2022)

Table EMEA Human Milk Oligosaccharides (HMO) Sales (g) Forecast by Application (2017-2022)

Figure EMEA Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370